Open AccessTrimetazidine as a modifier of doxorubicin+cyclophosphamideinduced hyperdyslipidemia
Author(s) -
Ashot Avagimyan,
Lev Kakturskiy
Publication year - 2022
Publication title -
sibirskij žurnal kliničeskoj i èksperimentalʹnoj mediciny
Language(s) - English
Resource type - Journals
eISSN - 2713-2927
pISSN - 2713-265X
DOI - 10.29001/2073-8552-2022-37-2-105-111
Subject(s) - trimetazidine , regimen , dose , doxorubicin , cyclophosphamide , chemotherapy , medicine , lipid profile , cholesterol , analysis of variance , pharmacology , endocrinology , chemistry